John P. Gibbs

4.9k total citations
80 papers, 3.2k citations indexed

About

John P. Gibbs is a scholar working on Oncology, Immunology and Surgery. According to data from OpenAlex, John P. Gibbs has authored 80 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 20 papers in Immunology and 17 papers in Surgery. Recurrent topics in John P. Gibbs's work include Lipoproteins and Cardiovascular Health (14 papers), Cancer Immunotherapy and Biomarkers (10 papers) and Chemical Analysis and Environmental Impact (9 papers). John P. Gibbs is often cited by papers focused on Lipoproteins and Cardiovascular Health (14 papers), Cancer Immunotherapy and Biomarkers (10 papers) and Chemical Analysis and Environmental Impact (9 papers). John P. Gibbs collaborates with scholars based in United States, Canada and United Kingdom. John P. Gibbs's co-authors include John T. Slattery, Kenny S. Crump, Maciej Czerwiński, Megan Gibbs, Maurice G. Emery, Scott M. Wasserman, Jeannine S. McCune, Bill J. Smith, Antonio Dimida and Massimo Tonacchera and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and Environmental Science & Technology.

In The Last Decade

John P. Gibbs

79 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John P. Gibbs United States	32	725	662	653	514	507	80	3.2k
Yeong‐Shiau Pu Taiwan	42	718 1.0×	1.1k 1.7×	2.5k 3.9×	1.4k 2.8×	224 0.4×	312	7.0k
Ken‐ichi Miyamoto Japan	32	185 0.3×	769 1.2×	848 1.3×	295 0.6×	185 0.4×	164	2.9k
Noriko Nishimura Japan	30	941 1.3×	431 0.7×	1.2k 1.8×	116 0.2×	140 0.3×	130	3.0k
Venkata Sabbisetti United States	33	261 0.4×	249 0.4×	1.0k 1.6×	600 1.2×	213 0.4×	71	4.3k
Natascha A. Wolff Germany	29	416 0.6×	1.1k 1.6×	749 1.1×	127 0.2×	526 1.0×	44	2.6k
Kimie Sai Japan	32	306 0.4×	1.0k 1.5×	1.3k 1.9×	160 0.3×	339 0.7×	90	2.7k
Chuan‐Ming Hao China	43	112 0.2×	305 0.5×	2.2k 3.4×	702 1.4×	258 0.5×	186	6.9k
Robert Safirstein United States	42	94 0.1×	986 1.5×	2.5k 3.9×	551 1.1×	485 1.0×	89	5.9k
D Belpomme France	23	253 0.3×	710 1.1×	508 0.8×	181 0.4×	152 0.3×	102	2.5k
Songming Huang China	36	115 0.2×	216 0.3×	1.9k 2.9×	458 0.9×	249 0.5×	183	4.3k

Countries citing papers authored by John P. Gibbs

Since Specialization

Citations

This map shows the geographic impact of John P. Gibbs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John P. Gibbs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John P. Gibbs more than expected).

Fields of papers citing papers by John P. Gibbs

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John P. Gibbs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John P. Gibbs. The network helps show where John P. Gibbs may publish in the future.

Co-authorship network of co-authors of John P. Gibbs

This figure shows the co-authorship network connecting the top 25 collaborators of John P. Gibbs. A scholar is included among the top collaborators of John P. Gibbs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John P. Gibbs. John P. Gibbs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gao, Xiang, Anthony J. Olszanski, Gerald S. Falchook, et al.. (2024). 996MO Dazostinag (TAK-676) alone and in combination with pembrolizumab (pembro) in patients (pts) with advanced/metastatic solid tumors: Data from phase I dose escalation. Annals of Oncology. 35. S678–S679. 1 indexed citations

Yazıcı, Yusuf, T.E. McAlindon, Allan Gibofsky, et al.. (2021). A Phase 2b randomized trial of lorecivivint, a novel intra-articular CLK2/DYRK1A inhibitor and Wnt pathway modulator for knee osteoarthritis. Osteoarthritis and Cartilage. 29(5). 654–666. 73 indexed citations

Chiney, Manoj, Juki Ng, John P. Gibbs, & Mohamad Shebley. (2019). Quantitative Assessment of Elagolix Enzyme-Transporter Interplay and Drug–Drug Interactions Using Physiologically Based Pharmacokinetic Modeling. Clinical Pharmacokinetics. 59(5). 617–627. 21 indexed citations

Chen, Ping, Benjamin Wu, Per Olsson, et al.. (2017). Population Pharmacokinetic and Pharmacodynamic Modeling of Etelcalcetide in Patients with Chronic Kidney Disease and Secondary Hyperparathyroidism Receiving Hemodialysis. Clinical Pharmacokinetics. 57(1). 71–85. 7 indexed citations

Koren, Michael J., Sameer Doshi, John P. Gibbs, et al.. (2015). Abstract 12729: Comparisons of Peak LDL-C Reduction and Duration of Effect With Lower or Higher Dosing Regimens of the PCSK9 Inhibitor Evolocumab. Circulation. 132(suppl_3). 1 indexed citations

Gow, Jason M., Wayne Tsuji, Gary J. Williams, et al.. (2015). Safety, tolerability, pharmacokinetics, and efficacy of AMG 403, a human anti-nerve growth factor monoclonal antibody, in two phase I studies with healthy volunteers and knee osteoarthritis subjects. Arthritis Research & Therapy. 17(1). 282–282. 22 indexed citations

Davda, Jasmine, et al.. (2014). A model-based meta-analysis of monoclonal antibody pharmacokinetics to guide optimal first-in-human study design. mAbs. 6(4). 1094–1102. 36 indexed citations

Gibbs, John P., et al.. (2012). Quantitative Model of the Relationship Between Dipeptidyl Peptidase‐4 (DPP‐4) Inhibition and Response: Meta‐Analysis of Alogliptin, Saxagliptin, Sitagliptin, and Vildagliptin Efficacy Results. The Journal of Clinical Pharmacology. 52(10). 1494–1505. 35 indexed citations

Dias, Clapton, Adam J. Shaywitz, Scott M. Wasserman, et al.. (2012). Effects of AMG 145 on Low-Density Lipoprotein Cholesterol Levels. Journal of the American College of Cardiology. 60(19). 1888–1898. 202 indexed citations

10.

Dias, Clapton, Adam J. Shaywitz, Brian D. Smith, et al.. (2011). Abstract 10701: A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Ascending Single Dose Study to Evaluate the Safety, Tolerability and Pharmacodynamics of AMG145. Circulation. 124. 8 indexed citations

11.

Dong, Jennifer, David H. Salinger, Christopher J. Endres, et al.. (2011). Quantitative Prediction of Human Pharmacokinetics for Monoclonal Antibodies. Clinical Pharmacokinetics. 50(2). 131–142. 119 indexed citations

12.

Greene, Robert J., Hua Tu, John P. Gibbs, & J. Greg Slatter. (2011). Target-mediated metabolism and target-mediated drug disposition of the DPPIV inhibitor AMG 222. Xenobiotica. 41(11). 945–957. 9 indexed citations

13.

Liu, Xingrong, Bill J. Smith, Cuiping Chen, et al.. (2006). Evaluation of Cerebrospinal Fluid Concentration and Plasma Free Concentration As a Surrogate Measurement for Brain Free Concentration. Drug Metabolism and Disposition. 34(9). 1443–1447. 129 indexed citations

14.

Crump, Kenny S. & John P. Gibbs. (2005). Benchmark Calculations for Perchlorate from Three Human Cohorts. Environmental Health Perspectives. 113(8). 1001–1008. 36 indexed citations

15.

Gibbs, John P., Arnold Engel, & Steven H. Lamm. (2005). The NAS Perchlorate Review: Second-Guessing the Experts. Environmental Health Perspectives. 113(11). A727–A728. 3 indexed citations

16.

Gibbs, John P., Moji Christianah Adeyeye, Ziping Yang, & Danny D. Shen. (2004). Valproic acid uptake by bovine brain microvessel endothelial cells: role of active efflux transport. Epilepsy Research. 58(1). 53–66. 50 indexed citations

17.

Williams, John A., Susan Hurst, Jonathan Bauman, et al.. (2003). Reaction Phenotyping in Drug Discovery: Moving Forward with Confidence?. Current Drug Metabolism. 4(6). 527–534. 39 indexed citations

18.

Crump, Casey, Carlos M. Reyes, Gilberto González, et al.. (2000). Does Perchlorate in Drinking Water Affect Thyroid Function in Newborns or School-Age Children?. Journal of Occupational and Environmental Medicine. 42(6). 603–612. 83 indexed citations

19.

Petros, William P., Joshua D. Rabinowitz, John P. Gibbs, et al.. (1998). Effect of Plasma TNF‐α on Filgrastim‐Stimulated Hematopoiesis in Mice and Humans. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 18(4). 816–823. 3 indexed citations

20.

Gibbs, John P., et al.. (1998). Evaluation of a Population With Occupational Exposure to Airborne Ammonium Perchlorate for Possible Acute or Chronic Effects on Thyroid Function. Journal of Occupational and Environmental Medicine. 40(12). 1072–1082. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact